Efficacy of Shipixiaoji Granules, Lenvatinib, and Tislelizumab in Patients with Unresectable Hepatocellular Carcinoma: Protocol for a Prospective, Single-Arm, Phase II Trial

Authors
Category Primary study
JournalNATURAL PRODUCT COMMUNICATIONS
Year 2024
This article has no abstract
Epistemonikos ID: 02681b49cddf991abcbf498bb6d25f87972d6042
First added on: Feb 19, 2025